Back to Markets
PRPrime Medicine, Inc

Prime Medicine, Inc

PRMENASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$3.55

+0.1500 (+4.41%)

As of 05/29/26 EDT · USD

Compare
Low: $1.18Current: $3.55High: $6.94

Key Statistics

Open

$3.39

Day High

$3.56

Day Low

$3.26

Prev. Close

$3.40

VolumeShares traded today.

3.25M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$641.19M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-2.82

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$6.94

52W LowLowest price over the past 52 weeks.

$1.18

50D MAAverage closing price over the last 50 trading days.

$3.42

200D MAAverage closing price over the last 200 trading days.

$3.98

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+20.3%

1M

+0.6%

6M

-4.6%

YTD

+0.6%

1Y

+200.8%

About

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

primemedicine.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade PRME

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.